Fred Hutchinson Cancer Center
The Basic Sciences Division of Fred Hutch Cancer Center seeks a visionary scientific leader to accelerate discoveries in fundamental biology relevant to cancer and other diseases. This faculty position targets Associate and Full Professors with research interests in Immunotherapy, Precision Oncology, Data Science, or Viruses and Vaccines. The role offers generous startup funds, an endowed chair, and resources for collaborations and additional recruitment.
Fred Hutchinson Cancer Center is a nonprofit research and treatment organization dedicated to eliminating cancer and related diseases. It combines laboratory research, clinical trials, and patient care to improve prevention and treatment across cancers as well as related conditions such as HIV/AIDS and autoimmune diseases. Fred Hutch provides comprehensive patient services (appointments, MyChart, provider and referral resources) and works closely with physicians and partner institutions to translate discoveries into new therapies. The center is known for rigorous science and integrated clinical programs that move innovations from bench to bedside.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Fred Hutchinson Cancer Center.
Fred Hutchinson Cancer Center didn’t post a salary, so this is our estimate from similar listings.
28% above the average for this role
Assistant or Associate Professor
fredhutchinsoncancercenter.com
Faculty in Synthetic Biology #BSD036
University of Chicago
Assistant, Associate, or Full Professor – Cancer Immunology and Immunotherapy
fredhutchinsoncancercenter.com
Postdoctoral Associate - Cancer Gene Therapy
CA.gov
Assistant Professor
Dartmouth College
Assistant Professor (Tenure-Track) – Neurodegeneration Biology and Cancer Biology
Texas A&M University